Fast Growing Pharmacovigilance SaaS Leader

Gross Revenue

$3,000,000

EBITDA

$1,000,000

© 2025 MergersCorp M&A International is a global brand operating through a number of professional firms and constituent entities (“Members”) located throughout the world to provide Investment Banking, Corporate Finance, and Advisory Services and other client-related professional services. The Member Firms (“Members”) are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit our Disclaimer: https://mergerscorp.com/disclaimer. MergersCorp M&A International's franchising program is not offered to individuals or entities located in the United States.

The franchising program is offered by MergersUK Limited, a UK Company with its registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom.

MergersCorp M&A International provides strategic business advisory services, including preparing companies for growth and capital access. Through partnerships with licensed investment bankers, clients can access tailored capital-raising solutions.

U.S. Investment Banking Securities transactions are exclusively conducted by Spektrum Capital Advisors LLC, a Registered Representative of, and Securities Products offered through, BA Securities, LLC, a FINRA-registered broker-dealer. Check the background of investment professionals associated with this site on Broker Check.

Contact M&A Advisor

Amount You Can Invest

Purchase Timeframe (Months)

Message to the M&A Advisor

Yes, send me updates on new and featured Business listings for sale.You agree to MergersCorp’s Terms of Use & Privacy Policy.

Return to Listings

Fast Growing Pharmacovigilance SaaS Leader

Description

India

Business ID: L#20250961

A fast-growing, cloud-native SaaS company headquartered in Bangalore with offices in the US, UK, and Europe, specializing in pharmacovigilance (PV) and clinical trial IT solutions for the global life sciences industry. The company offers an all-in-one platform combining intake, case processing, regulatory submissions, and signal detection — reducing IT costs by up to 70% and time-to-compliance by 30%.

Founded in 2017, the company has a domain-specialized team of 65+ employees based in India and supports 100+ direct clients and over 160 end clients across more than 15 countries.

Core Platform Capabilities

Unified PV database with AS2 Gateway
Web, email, and MICC intake modules
Case processing, auto-narratives, signal detection
E2B R2/R3 support and real-time analytics
Integrated CTMS, EDC, eTMF, ePRO, IWRS, and eConsent modules

Differentiation

AI-powered automations for case booking, triage, and processing
End-to-end unified system (vs. fragmented tools in legacy stacks)
Inbuilt regulatory compliance tools (e.g., submissions, reporting)
Trusted by top 3 of India’s top 10 pharma companies

Strategic Footprint

Strong presence in India, USA, UK, and broader Europe
Embedded in global CROs and expanding via partnerships (e.g., Wipro, Persistent, Cognizant)
Actively used across 250+ clinical studies